Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The program established a favorable safety profile but the Phase IIb endpoint did not differentiate sufficiently from placebo to support continued development for obesity
Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al
Among other things, there can be no guarantee that future study results will be consistent with the results to date, that Zepbound will receive additional regulatory approvals, that Zepbound will be commercially successful, or that Lilly will execute its strategy as planned
Key Comparison: A 120 lb woman who drinks 2 standard drinks reaches approximately 0.08% BAC the US legal driving limit
While you look forward to your appointment, you can peruse our blog for informative posts about the other kinds of treatments we offer
Find articles by Wise, J
US$ 22.53
US$ 25.45
US$ 23.69
